Osteoblastoma is a benign local aggressive tumor mostly localized in the vertebra or long bones. Carpal location and recurrence are extremely rare. Treatment options include either curettage or wide en bloc resection which causes functional disability in the hand and wrist and should be reserved only for recurrence. We present a case of recurrent trapezoid osteoblastoma previously treated with curettage of the trapezoid bone and a case of primary triquetral osteoblastoma. Key words: Curettage; osteoblastoma; trapezoid bone; triquetral bone.
Osteoblastoma is a benign primary bone tumor first described as "giant osteoid osteoma" by Dahlin and Johnson in 1954. [1] Later, in 1956, Lichtenstein and Jaffe named this tumor "osteoblastoma" in two different articles. [2] It is an uncommon benign but locally aggressive tumor, most commonly located in the vertebral column or metaphysis of long bones. This tumor is very rare in the carpal bones. [2, 3] Trapezoid bone location is uncommon and has not been previously addressed in the literature. We report a case of a recurrent osteoblastoma in the trapezoid bone, previously treated with curettage of the trapezoid bone, as well as a case of primary triquetral osteoblastoma.
Case report Case 1
A 12-year-old girl presented to our clinic with posttraumatic left hand pain and swelling in February 2008. The pain increased at night and had a good response to nonsteroidal analgesic drugs. Radiographs, computerized tomography and magnetic resonance imaging (MRI) revealed findings resembling avascular necrosis of the trapezoid bone, periosteal reaction at the second metacarpal and generalized edema in the dorsal compartment (Figs. 1a and b) . Pathological evaluation of the sample of the lesion obtained by curettage was consistent with osteoid osteoma or osteoblastoma (Fig. 1c) . Clinically, the lesion was accepted as osteoid osteoma. The patient was completely free of pain and swelling with full range of wrist motion at the 12th month followup. However, at the 18th month follow-up, the patient had recurrent pain and swelling in the left hand. An osteolytic recurrent lesion of 23-mm diameter located in the trapezoid bone but expanding across the capitate bone was detected in the radiographs and MRI. Initial diagnosis was osteoblastoma and the lesion was excised with curettage. No adjuvant treatment was applied.
Osteoblastoma of the trapezoid bone and triquetral bone: report of two cases
Pathological evaluation of the samples revealed osteoblastoma. The patient had complete pain relief and no swelling with sufficient grasp strength at the postoperative 35th month. Osseous fusion of the carpometacarpal and intercarpal bones was detected in follow-up radiographs (Fig. 1d ).
Case 2
In June 2011, a 19-year-old male presented to our clinic with persistent right hand pain of a duration of two years. The patient took analgesic drugs consistently and the pain increased at night. Radiologic examination revealed a locally sclerotic lesion of 20-mm diameter in the triquetral bone (Figs. 2a, b and c). Curettage and grafting of the lesion was performed and pathological examination defined the lesion as osteoblastoma (Fig.  2d) . The patient had dramatic relief of complaints after the operation and was free of pain with full range of wrist motion and full grasp strength at the 13th month follow-up. There was no sign of recurrence in radiologic examination.
Discussion
Osteoblastoma, a benign but locally aggressive tumor, constitutes 1% of all bone tumors. [2] [3] [4] It is most commonly located in the vertebral column (40%), pelvis and long bones. Carpal location is extremely rare. In total, nine cases have been reported, with the navicular bone was affected in 5 cases, triquetral bone in 1 and hamate bone in 4 ( Table 1) . Trapezoidal bone location has not been previously addressed in the literature. The young population between 10 and 25 years of age and males are more often affected. [2] Gdoura et al. reported that pain has no specific pattern and no correlation with rest or activity or time of day and that non-steroidal anti-inflammatory drugs do not relieve pain. [2] However, non-steroidal anti-inflammatory drugs provided good pain relief in our cases in which pain had circadian characteristics.
In the presence of cortical destruction, the osteoblastoma is separated from the adjacent tissue by a reactive bony shell. In our recurrent case, cortical disruption was noted. Giant cell bone tumor, aneurysmal bone cyst, chondrosarcoma and osteosarcoma should be taken into consideration in the differential diagnosis in cases with cortical destruction.
[2] Dorfman and Weiss pointed out the importance of differential diagnosis between osteolytic aggressive osteoblastoma and well-differentiated osteosarcoma. 
Microscopically, the tumor consists of more vascularized connective tissue and has a greater diameter and has less reactional tissue surrounding the tumor than osteoid osteoma (greater than 2 centimeters) which has similar microscopic findings. [6, 7] Despite its benign character, early recurrence (10 to 19%) and malign transformation, even with pulmonary metastasis, can occur. [2, [8] [9] [10] In curettage of osteoblastoma, the bone window must be at least the same size as the tumor diameter as tumor cells left in the bone may cause recurrence. Curettage must be performed carefully using a burr motor. Bone grafting should be performed following curettage if necessary. Menon et al. treated a recurrent osteoblastoma in the hamate bone with curettage and grafting. [11] Van Dijk et al. treated a recurrent osteoblastoma in hamate bone with en bloc resection and temporary interposition of the dead space with cement followed by vascularized iliac bone graft. [8] In general, wide resection is the suggested treatment method but considering the consequent functional and constitutional morbidity it should be reserved as the last choice.
In conclusion, carpal osteoblastoma is an extremely rare benign but locally aggressive tumor. Diagnosis is difficult due to ambiguous symptoms and radiographic findings. Treatment is curettage and graft augmentation when necessary. In aggressive cases when the tumor progression is rapid, wide resection may be the preferred treatment. However, considering its consequent catastrophic results, this should be saved as the last treatment option. Well-differentiated osteosarcoma must be considered in the differential diagnosis.
Conflicts of Interest:
No conflicts declared.
